financetom
Business
financetom
/
Business
/
Mediobanca shareholders reject Banca Generali deal in blow to takeover defence
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mediobanca shareholders reject Banca Generali deal in blow to takeover defence
Aug 21, 2025 5:36 AM

MILAN (Reuters) -Mediobanca shareholders on Thursday rejected a plan to buy Banca Generali, dealing a blow to the Italian merchant bank's attempts to thwart a hostile takeover by Monte dei Paschi di Siena (MPS).

The bid battles are among a series of transactions which have been reshaping Italy's banking landscape as companies look for scale.

Mediobanca had pitched the Banca Generali plan, which would have created Italy's second-largest wealth manager, as an alternative to the MPS transaction.

The higher share price multiples at which wealth managers such as Banca Generali trade could have also lifted Mediobanca's valuation.

Opposition to the plan was led by Mediobanca's two main investors, Italy's billionaire Del Vecchio and Caltagirone families, who together hold nearly 30% of its capital, and have long been at loggerheads with CEO Alberto Nagel.

The families are also leading private shareholders in MPS and back its hostile bid for Mediobanca.

A takeover of Mediobanca, a former lynchpin of Italian capitalism now active in wealth management, by more retail-focused MPS has the blessing of the government which believes it will strengthen the industry in Italy.

Nagel in April proposed a 6.8 billion euro ($7.9 billion) deal to buy Banca Generali, which is owned by Generali, Italy's biggest insurer, whose key investors are Mediobanca, the Del Vecchios and the Caltagirones.

NAGEL RUES 'MISSED OPPORTUNITY'

After the vote, Mediobanca declared the Banca Generali bid had lapsed. Nagel lamented the impact of the complex web of cross-ownerships on the outcome.

"This is clearly an opportunity, for now, missed for the development of our bank and the Italian financial system," Nagel, who has led Mediobanca since 2008, said in a statement.

He added that it was down in part to "shareholders who also expressed a clear conflict of interest in their engagement activities, putting (their interests) relating to other Italian situations/assets before those of Mediobanca shareholders."

Delfin, the holding company of the late Ray-Ban billionaire Leonardo Del Vecchio, declined to comment. However, a source close to the holding company said that "the vote was an expression of concerns about the unusual methods and timing of the transaction rather than its strategic rationale".

A spokesperson for the Caltagirone family did not immediately respond to a request for comment.

Mediobanca owns 13% in Generali that Nagel had aimed to use to buy Banca Generali.

Under Italian takeover rules, Mediobanca needed shareholder backing for the Banca Generali deal due to the MPS bid, which would have become more costly if Mediobanca had bought Banca Generali.

In Thursday's vote, 78% of Mediobanca's share capital was represented.

In total, 35% of shareholders backed the deal, mostly institutional investors, while 42% voted against or abstained, including the Caltagirones and Del Vecchios, meaning the required threshold of 50% of the bank's capital present at the meeting was not met.

Mediobanca had postponed the shareholder vote at the last minute in June as the proposal lacked sufficient support.

(Writing by Keith Weir and Andrea Mandala. Editing by Gavin Jones and Mark Potter)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chinese cosmetics firm Yatsen Q2 revenue rises
Chinese cosmetics firm Yatsen Q2 revenue rises
Aug 21, 2025
Overview * Yatsen Q2 2025 rev rises 36.8% yr/yr to RMB1.09 bln * Net loss narrows 77.2% to RMB19.5 mln, non-GAAP net income positive * Gross margin improves to 78.3%, driven by higher-margin product sales Outlook * Yatsen expects Q3 2025 net revenues between RMB778.6 mln and RMB880.1 mln * Company forecasts Q3 2025 revenue growth of 15% to 30%...
Johnson & Johnson to invest $2 billion to boost US manufacturing as drug tariffs loom
Johnson & Johnson to invest $2 billion to boost US manufacturing as drug tariffs loom
Aug 21, 2025
(Reuters) -Johnson & Johnson ( JNJ ) committed to invest $2 billion in North Carolina on Thursday to expand the drugmaker's U.S. manufacturing presence as potential drug import duties from President Donald Trump's administration loom. J&J said it plans to build a new facility at Tokyo-based Fujifilm Diosynth's manufacturing site in Holly Springs, North Carolina, over the next 10 years....
Alvotech Says European Commission Approved Mynzepli to Treat Retinal Diseases
Alvotech Says European Commission Approved Mynzepli to Treat Retinal Diseases
Aug 21, 2025
05:29 AM EDT, 08/21/2025 (MT Newswires) -- Alvotech ( ALVO ) and UK-based Advanz Pharma said Thursday that their Mynzepli fusion protein was approved by the European Commission to treat retinal diseases, including neovascular age-related macular degeneration. The companies said the approval was based on non-clinical and clinical similarity data, which included a confirmatory efficacy study comparing Mynzepli with Bayer's...
Yatsen Reports Q2 Adjusted Earnings, Higher Revenue; Q3 Sales Outlook Set
Yatsen Reports Q2 Adjusted Earnings, Higher Revenue; Q3 Sales Outlook Set
Aug 21, 2025
05:25 AM EDT, 08/21/2025 (MT Newswires) -- Yatsen Holding ( YSG ) reported Q2 non-GAAP earnings Thursday of 0.13 Chinese renminbi ($0.02) per diluted American depositary share, swinging from a loss of 0.67 renminbi a year earlier. Analyst estimates were not readily available for comparison. Net revenue for the quarter ended June 30 was 1.09 billion renminbi, compared with 794.5...
Copyright 2023-2025 - www.financetom.com All Rights Reserved